chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"My left arm has been weak since 2nd shot"; body aches; "It's like a dead arm from someone punching it"; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, the patient experienced his left arm had been weak since 2nd shot. It was like a dead arm from someone punching it. Felt the weakness every time he lifted the objects or himself. The patient also experienced body aches that lasted one day after shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event "My left arm has been weak since 2nd shot", "It's like a dead arm from someone punching it" was not resolved. The clinical outcome of the event body aches was resolved on 24Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Received tetanus/diphtheria vaccine on 6/26/03.  That evening, noted low grade fever and myalgias; fever to 101 and generalized myalgias within 24 hours.  72 hours following vaccination, noted erythema, induration, pruritis at site of injection.  Still with low grade fever, myalgias; using advil q6 hours.
left shoulder pain since flu shot reported on 3/22/18 noted capsulitis in left humeral joint on XR. offered recheck with XR shoulder and PT or Ortho referral -pt refused.
Mother of baby called reporting rash-papular appearing with circular reddened area surrounding (1cm). Rash is now over legs, arms, trunk and in clusters. Child is eating and drinking well. Temp 100. Advised mother to take child to doctor. She returned call to say it was probably a virus.
Palpitations  Fast heart rate  Fatigue  Moderate body aches  Moderate chills Headache  Nausea  Sob- may be anxiety related
Pt vaccinated with Pfizer-BioNTech COVID-19 Vaccine EUA (# FD8448).  Pt waited in post-vax area for 15 minutes without complaint.  When her time was up, she went into the restroom.  While in restroom Pt had 3 episodes of vomiting.  Pt exited restroom hyperventilating and was being assisted to vehicle by RN and husband when she had a syncopal episode.  Pt was assisted to ground by RN, did not fall, and did not suffer any trauma.  Pt denied chest pain or other discomfort and was A/O x4, however was only speaking in one-word sentences.  911 was activated at 1539.  Passive cooling measures were taken and attempts were made to coach Pt to slow her breathing.  Fire and EMS arrived approximately 1548 and took over Pt care.  Pt transported to by EMS.
Mother reported that pt complains that left arm was tingling, numb and feels restless at times.
Patient forgot she received flu shot in Oct and returned for a flu shot.  She received one in Oct and 2nd one on 11/15/21. Patient stated she had headache and body aches approximately 12 hours after vaccine.  Had nose bleed 24 hours after 2nd dose.
pretty bad reactions; residual issues; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (pretty bad reactions) and ILL-DEFINED DISORDER (residual issues) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (pretty bad reactions) and ILL-DEFINED DISORDER (residual issues). At the time of the report, VACCINATION COMPLICATION (pretty bad reactions) and ILL-DEFINED DISORDER (residual issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant information provided. No treatment information provided.
Patient vaccinated with first dose of Pfizer at 11:45 am on 5/1/2021. Patient sat in EMT observation area. At 11:50 am, patient's sister noticed patient going out of consciousness and called for help. EMT transferred patient to anti-gravity chair and monitored vitals. Vitals WNL at 11:54 am and 11:59 am. Patient left facility at 12:05 pm with steady, balanced gait.
no adverse affects; improperly stored dose of PROQUAD was administered to a patient; This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 24-APR-2019, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # R026717, expiration date: 17-MAR-2020 (exact dose, site and route of administration were not reported). It was unknown how the sterile diluent used to reconstitute the administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored. No adverse effects were reported. The vaccines were exposed to a temperature of 70 degree Fahrenheit (F) for a time frame of 2 hours. The digital data logger was involved in recording the temperature details. There was no previous temperature excursion.
my feet are very red and have large water blisters; my feet are very red and have large water blisters; feel very hot on feet; This is a spontaneous report from a contactable consumer (patient). This patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration in Apr2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had the vaccine a week ago (Apr2021) and now the feet were very red and had large water blisters and felt very hot on feet. The outcomes of feet were very red, large water blisters, and very hot on feet were unknown.   No follow-up attempts are possible; information about batch/lot number cannot be obtained.
1st dose 18Sep2019, has not received 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 18th September 2019,(batch number BP578, expiration date 20th December 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 25-APR-2022 Reporter's Comment: The patient received first dose of Shingrix series and had not yet received second dose. The Reporter gave permission for follow-up via phone, declined to provide email address. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. This case has been linked with case US2022AMR070604, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR070604:Same reporter.
Throat constriction sensation 4 hrs after flu shot - resolved spont after approximately 8-10 hrs.
Patient fell to the floor as soon as the  shot was given and started convulsing and making jerky movements (looked as if he was having a seizure).   Lasted 30 seconds.  First shot that was given was HPV, then Tdap, then MCV4
INJECTION SITE HAD A LARGE RED WELT WITHIN MINUTES, THAT WAS ABOUT 1 INCH IN DIAMETER. IT WAS BRIGHT RED, RAISED, AND VERY FIRM TO THE TOUCH.  BY 2PM AFTER THE INJECTION, SHE WAS COVERED IN MILD HIVES ALL OVER HER CHEST, STOMACH, BACK, AND BUTTOCKS.  BOTH THE RED WELT AND HIVES STAYED CONSISTENT IN APPEARANCE FOR 3 DAYS. UPON WAKING ON THE 4TH DAY, THE HIVES WERE GONE.  THE REDNESS AT THE INJECTION SITE WAS GONE, BUT THE INJECTION SITE IS STILL RAISED AND FIRM TO THE TOUCH (TODAY IS DAY 5).
Bullous hypersensitivity reaction characterized by erythema, induration, swelling and tense bullae on left arm
Symptoms began 8/18: small patch of itchy blisters erupted in posterior aspect of left thigh, RUQ over next few days, several single vesicle-like eruption appeared on both lower legs on the medial aspect of both knees and on the back of my right thigh. 8/20 another small patch of blisters - appeared this time on inner aspect of right thigh (high) all patches and vesicular have itched and were or are fluid filled no pain 8/30 Vesicles cont to appear.
Pt suffers from petit mal seizures. Pt reports increased seizure activity after GARDASIL.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 19Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 28 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing); "asthma" (unspecified if ongoing); "known allergies: Gluten" (unspecified if ongoing), notes: known allergies: Gluten. The patient took concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20Jun2022) Positive, notes: faded/light antigen tests; (21Jun2022) Positive, notes: faded/light antigen tests; (22Jun2022) Negative; (23Jun2022) Negative; (25Jun2022) Positive, notes: Instant, dark red positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 with paxlovid from 13Jun2022 to 18Jun2022. Clinical Course: The patient previously received a covid19 vaccine. The patient was taking any other medications/products within 2 weeks of starting COVID-19 treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. The reporter reported that a patient received GARDASIL (lot# was not reported) on 12-APR-2012 and the patient  was  in the office to receive the second dose on 25-FEB-2013. No adverse effect reported. Additional information has been requested.
Information has been received from a registered nurse concerning a 20 years old female patient, who was administered 3 dose of RECOMBIVAX HB (doses, routes and lot numbers not reported) on unspecified dates as an infant, and was now found to have negative antibody titers. No treatment was given for AE. The patient's present status was reported as other: negative antibody titers (not recovered, at the time of the report). The relatedness for the event was unknown for RECOMBIVAX HB. Laboratory diagnostic studies were performed: antibody titers. The patient sought medical attention via office visit. Additional information is not expected.
Patient c/o immediately of lightheadness after receiving injection. Site right deltoid became swollen and had hard lump. Lightheadness lasted about 5 mins. Wns able to stand without problems after 5 mins. No other problems were noted. Lump had decreased in size when client left the clinic. Instructed patient to let MD know about reaction. Called patient at 1250 pm and client was feeling good. 322 pm - still had swollen arm area on right deltoid. No other problems.
After receiving his second dose of vaccine, patient walked and sat down in the waiting area to be monitored and soon started feeling light headed. I approached him and he was losing consciousness and starting turning pale. He was also profusely sweating. I called 911 and EMS soon arrived and took his vitals. His wife gave EMS his history and told them this happens when he has blood drawn. This did not happen after his first dose of Moderna vaccine. He was lying down on his side. EMS took an EKG and said his heart looked good. His blood pressure was 120/90. After 10 minutes patient said he was feeling fine and did not want to go to the hospital. He answered all of EMS's questions correctly such as "Where are you?" "What year is it?" "Who is the president?" " How many quarters are in a dollar?" Patient went home with his wife and said he will follow up with his doctor. I will call him tomorrow on 6-18-21 to see how he is doing.
Information has been received from a nurse practitioner concerning a 16 year old female with allergy to horses who on 10-SEP-2008, was vaccinated with GARDASIL (lot no. 660553/0070X) 0.5 mL, IM. There was no concomitant medication. On 10-SEP-2008, about 90 minutes after vaccination, the patient experienced numbness of her tongue and roof of her mouth. Within an hours, the patient recovered without treatment. No laboratory tests were performed. The patient sought unspecified medical attention. Additional information has been requested.
Aggressive behavior   Impulse control disorder   Autism spectrum disorder without accompanying - behavioral health admission within 6 weeks of receiving the COVID vaccine.
Patient was waiting because I told them to wait for any reactions, 5 minutes later he passed out. I gave him EPIPEN 0.3 auto-injector and he awaked, took him to urgent care, called 911. His BP was really low so he was sent to ER.
At around 3am on 4/9/21 I woke up and could barely move due to all over body aches. I was chilling and had severe headache and fever of 101.8
Approximately 20 minutes after receiving the shot (approx. 5:00 p.m.), I felt the glands at the bottom of my neck started swelling.  The swelling continued up my neck  and into my jaw line.  I felt a very small swelling in my throat area from the glands, but had no trouble breathing.  Once I arrived home (approx. 5:15 p.m.) I took 3 Advil.  The swelling went away before 6:00 p.m. and I've felt fine ever since.  No other adverse reactions noted.
Seen on 04/23/2002. Mom states child had chicken pox two weeks ago.
Patients states he has difficulty raising his arm above his head and also holding his arm out in front of him. He has tried ALEVE, warm compress, cold compress, ASPERCREME, BIOFREEZE and massaging. It has continued to give him pain ever since the injection date (20 days). Patient was advised to seek out his PCP.
Fever, malaise, fatigue, left axillary adenopathy. Rx: acetomengsten, ibuprofen, 2 days off work
Altered mental status R77.8 - Elevated troponin N39.0, R31.9 - Urinary tract infection with hematuria, site unspecified D64.9 - Anemia, unspecified type R40.2431 - Glasgow coma scale total score 3-8, in the field (EMT or ambulance)
pt recv vax;exp red swollen face,itching,burning and facial pain;to MD;face dry w/ pulling & drawing;the sun seemed to aggravate condition;noticed p/ each vax,facial rash seemed to get worse;
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patients' pertinent medical history and drug reactions or allergies were not provided. On an unknown date, the patient was inadvertently vaccinated with improperly stored dose of VARIVAX (lot # N015475, expiration date: 18-MAY-2019, dose, frequency and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MRK). Reporter stated that the vaccines were stored between -14 degrees Celsius to -10 degrees Celsius for 21 minutes prior to administration. There were no previous temperature excursions. The digital data logger was used. The patients did not experienced any adverse events. Product quality complaint was not involved.
Patient started feeling itching and warm at injectin site. Redness spread about 6 to 7 inches from injection site. Pt applied hydrocortisone cream otc. Patient was told by pharmD to take Benadryl and then later decided to go to emergency room to get checked. ER prescriber gave her a prescription for prednisone to take along with zantac. She also recommended zyrtec.
Having chills, mild cough, congestion and sore a throat. Took home COVID-19 and was positive. Had a Telehealth appointment and was prescribed PAXLOVID. Started feeling better a few days later.
This spontaneous report received from a nurse refers to a patient of unknown age. Information on pertinent medical history and concurrent condition was not provided. Information on pertinent medical history and concurrent condition was not provided. On an unknown date, the patient was vaccinated with VARIVAX lot # M005971 for prophylaxis. The Nurse reported that the vaccine administered was improperly stored. No adverse event reported. The outcome of incorrect product storage and no adverse event was unknown. Lot M005971 was stored at 12°C for 63 hours, and in the range of -14°C to-10°C for 487.5 hours. No previous temperature excursion. The call was not because of a "data logger" Additional information has been requested.
Exhaustion and fever the day after the shot. Symptoms continued to get worse as time went on. On 9/10/21 patient became light headed and had difficulty maintaining balance. The fever continued. On 9/18/21 patient went to the hospital with symptoms of exhaustion, light headedness, falling down, right leg numbness and back pain. As of 9/24/21 patient still had not recovered. As of 11/9/21 patient has had relief from most back pain but other symptoms have persisted.
One day after vaccine pink area around injection site L thigh. Pink localized rxn, nontender, slightly warmth, no fever 10x12cm.
CHILLS, ELEVATED RESPIRATORY RATE, ELEVATED HEART RATE, FATIGUE
Lingering metallic taste; Sharp headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Sharp headache) and DYSGEUSIA (Lingering metallic taste) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced HEADACHE (Sharp headache) and DYSGEUSIA (Lingering metallic taste). On 30-Dec-2020, HEADACHE (Sharp headache) and DYSGEUSIA (Lingering metallic taste) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
not feeling well; vomiting; diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date 05Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE; manufacture unknown), for COVID-19 immunization. The following information was reported: MALAISE (non-serious) with onset 05Apr2021, outcome "unknown", described as "not feeling well"; VOMITING (non-serious) with onset 05Apr2021, outcome "unknown", described as "vomiting"; DIARRHOEA (non-serious) with onset 05Apr2021, outcome "unknown", described as "diarrhea".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old male patient received BNT162b2 (BNT162B2), on 23Jan2021 at 10:15 as dose 1, single (Batch/Lot number: unknown), in left arm and on 02Feb2021 at 11:00 as dose 2, single (Batch/Lot number: unknown) at the age of 75 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: COVID-19 (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of covid-19 included: PAXLOVID. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
on 2/26 at 11 am I started with my joints aching then it went to chills and then flu symptoms.  No nausea.  On that evening my arm started to become feverish, red, swollen and painful to touch with itching.  It became worse on 2/27.  I have a picture.  I have applied ice and cortisone itch cream which has helped.  I woke up this morning on 3/3 with my arm fully recovered.
mild fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (mild fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (mild fever). At the time of the report, PYREXIA (mild fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported No treatment medication was reported   This case was linked to MOD-2021-013595 (Patient Link).